With drug-resistant bacteria on the rise, even common infections that were easily controlled for decades are proving trickier to treat with standard antibiotics. New drugs are desperately needed, but so are ways to maximize the effective lifespan of these drugs. To accomplish that, researchers used software they developed to predict a constantly-evolving infectious bacterium's counter-moves to one of these new drugs ahead of time, before the drug is even tested on patients.
With drug-resistant bacteria on the rise, even common infections that were easily controlled for decades are proving trickier to treat with standard antibiotics. New drugs are desperately needed, but so are ways to maximize the effective lifespan of these drugs. To accomplish that, researchers used software they developed to predict a constantly-evolving infectious bacterium's counter-moves to one of these new drugs ahead of time, before the drug is even tested on patients.
Share this Article
Recommended